Foot and Mouth Disease Virus Antibody (serotype O1) |
GWB-6C1896 |
GenWay Biotech |
0.2 mg |
Ask for price |
Human IgG antibody Laboratories manufactures the dengue virus serotype antibody reagents distributed by Genprice. The Dengue Virus Serotype Antibody reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact virus Antibody. Other Dengue products are available in stock. Specificity: Dengue Category: Virus Group: Serotype Antibody
Human Rubella Virus IgG Antibody ELISA Kit |
Abbexa |
96 tests |
EUR 548.4 |
|
Human Influenza Virus IgG Antibody ELISA Kit |
Abbexa |
96 tests |
EUR 801.6 |
|
Human Rubella Virus IgG Antibody ELISA Kit |
Abbexa |
96 tests |
EUR 801.6 |
|
Human Rabies virus Antibody IgG ELISA Kit |
Abbexa |
96 tests |
EUR 801.6 |
|
Human Rubella virus antibody IgG ELISA Kit |
Abclonal |
96Tests |
EUR 625.2 |
Human Rabies Virus IgG Antibody ELISA Kit |
MyBiosource |
10x96-Strip-Wells |
EUR 6255 |
Serotype Antibody information
Dengue Virus Serotype 1 VLP |
DENV1-VLP-500 |
The Native Antigen Company |
0.5 |
EUR 3164.83 |
|
Description: Recombinant Dengue Virus serotype 1 virus-like particle recombinant antigen consisting of Envelope, pre-Membrane and Membrane protein produced in 293 human cells. The C-terminal 20% of the dengue Envelope protein was replaced by the corresponding Japanese encephalitis virus SA-14 sequence (Envelope protein amino acids 399-497). The replaced sequence corresponds to the transmembrane and intraparticle portion of the protein. |
Dengue Virus Serotype 1 VLP |
DENV1-VLP-5000 |
The Native Antigen Company |
N/A |
EUR 919.32 |
|
Description: Recombinant Dengue Virus serotype 1 virus-like particle recombinant antigen consisting of Envelope, pre-Membrane and Membrane protein produced in 293 human cells. The C-terminal 20% of the dengue Envelope protein was replaced by the corresponding Japanese encephalitis virus SA-14 sequence (Envelope protein amino acids 399-497). The replaced sequence corresponds to the transmembrane and intraparticle portion of the protein. |
Dengue Virus Serotype 2 VLP |
DENV2-VLP-100 |
The Native Antigen Company |
0.1 |
EUR 760.95 |
|
Description: Recombinant Dengue Virus serotype 2 virus-like particle recombinant antigen consisting of Envelope, pre-Membrane and Membrane protein produced in 293 human cells. The C-terminal 20% of the dengue Envelope protein was replaced by the corresponding Japanese encephalitis virus SA-14 sequence (Envelope protein amino acids 397-495). The replaced sequence corresponds to the transmembrane and intraparticle portion of the protein. |
Dengue Virus Serotype 2 VLP |
DENV2-VLP-2500 |
The Native Antigen Company |
N/A |
EUR 3309.04 |
|
Description: Recombinant Dengue Virus serotype 2 virus-like particle recombinant antigen consisting of Envelope, pre-Membrane and Membrane protein produced in 293 human cells. The C-terminal 20% of the dengue Envelope protein was replaced by the corresponding Japanese encephalitis virus SA-14 sequence (Envelope protein amino acids 397-495). The replaced sequence corresponds to the transmembrane and intraparticle portion of the protein. |
Dengue Virus Serotype 2 VLP |
DENV2-VLP-500 |
The Native Antigen Company |
0.5 |
EUR 3309.04 |
|
Description: Recombinant Dengue Virus serotype 2 virus-like particle recombinant antigen consisting of Envelope, pre-Membrane and Membrane protein produced in 293 human cells. The C-terminal 20% of the dengue Envelope protein was replaced by the corresponding Japanese encephalitis virus SA-14 sequence (Envelope protein amino acids 397-495). The replaced sequence corresponds to the transmembrane and intraparticle portion of the protein. |
Dengue Virus Serotype 3 VLP |
DENV3-VLP-100 |
The Native Antigen Company |
0.1 |
EUR 919.32 |
|
Description: Recombinant Dengue Virus serotype 3 virus-like particle recombinant antigen consisting of Envelope, pre-Membrane and Membrane protein produced in 293 human cells. The C-terminal 20% of the dengue Envelope protein was replaced by the corresponding Japanese encephalitis virus SA-14 sequence (Envelope protein amino acids 399-492). The replaced sequence corresponds to the transmembrane and intraparticle portion of the protein. |
Dengue Virus Serotype 3 VLP |
DENV3-VLP-500 |
The Native Antigen Company |
0.5 |
EUR 3928.35 |
|
Description: Recombinant Dengue Virus serotype 3 virus-like particle recombinant antigen consisting of Envelope, pre-Membrane and Membrane protein produced in 293 human cells. The C-terminal 20% of the dengue Envelope protein was replaced by the corresponding Japanese encephalitis virus SA-14 sequence (Envelope protein amino acids 399-492). The replaced sequence corresponds to the transmembrane and intraparticle portion of the protein. |
Dengue Virus Serotype 4 VLP |
DENV4-VLP-100 |
The Native Antigen Company |
0.1 |
EUR 919.32 |
|
Description: Recombinant Dengue Virus serotype 4 virus-like particle recombinant antigen consisting of Envelope, pre-Membrane and Membrane protein produced in 293 human cells. The C-terminal 20% of the dengue Envelope protein was replaced by the corresponding Japanese encephalitis virus SA-14 sequence (Envelope protein amino acids 400-495). The replaced sequence corresponds to the transmembrane and intraparticle portion of the protein. |
Dengue Virus Serotype 4 VLP |
DENV4-VLP-250 |
The Native Antigen Company |
0.25 |
EUR 1839.93 |
|
Description: Recombinant Dengue Virus serotype 4 virus-like particle recombinant antigen consisting of Envelope, pre-Membrane and Membrane protein produced in 293 human cells. The C-terminal 20% of the dengue Envelope protein was replaced by the corresponding Japanese encephalitis virus SA-14 sequence (Envelope protein amino acids 400-495). The replaced sequence corresponds to the transmembrane and intraparticle portion of the protein. |
Dengue Virus Serotype 4 VLP |
DENV4-VLP-500 |
The Native Antigen Company |
0.5 |
EUR 3216.33 |
|
Description: Recombinant Dengue Virus serotype 4 virus-like particle recombinant antigen consisting of Envelope, pre-Membrane and Membrane protein produced in 293 human cells. The C-terminal 20% of the dengue Envelope protein was replaced by the corresponding Japanese encephalitis virus SA-14 sequence (Envelope protein amino acids 400-495). The replaced sequence corresponds to the transmembrane and intraparticle portion of the protein. |
Dengue Virus Serotype 2 Capsid (DENV-2 C) Antibody |
abx201278-100l |
Abbexa |
100 µl |
EUR 450 |
Dengue Virus Serotype 2 Capsid (DENV-2 C) Antibody |
abx201278-50l |
Abbexa |
50 µl |
EUR 312.5 |
Dengue Virus Serotype 2 Capsid (DENV-2 C) Antibody |
abx201279-100l |
Abbexa |
100 µl |
EUR 450 |
Dengue Virus Serotype 2 Capsid (DENV-2 C) Antibody |
abx201279-50l |
Abbexa |
50 µl |
EUR 312.5 |
Mouse Anti Dengue Virus NS1 Serotype 1 Antibody (OB4) |
MAB12132-100 |
The Native Antigen Company |
0.1 |
EUR 307.91 |
|
Description: Mouse monoclonal antibody specific for Dengue virus serotype 1 NS1 (clone OB4) |
Mouse Anti Dengue Virus NS1 Serotype 1 Antibody (OB4) |
MAB12132-500 |
The Native Antigen Company |
0.5 |
EUR 772.63 |
|
Description: Mouse monoclonal antibody specific for Dengue virus serotype 1 NS1 (clone OB4) |
Mouse Anti Dengue Virus NS1 Serotype 2 Antibody (JE1) |
MAB12134-100 |
The Native Antigen Company |
0.1 |
EUR 307.91 |
|
Description: Mouse monoclonal antibody specific for Dengue virus serotype 2 NS1 (clone JE1) |